Citigroup’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-56,100
Closed -$347K 7766
2018
Q3
$347K Buy
56,100
+3,300
+6% +$14.9K ﹤0.01% 4689
2018
Q2
$337K Sell
52,800
-4,500
-8% -$32K ﹤0.01% 4504
2018
Q1
$400K Buy
57,300
+48,200
+530% +$561K ﹤0.01% 4229
2017
Q4
$115K Sell
9,100
-13,400
-60% -$163K ﹤0.01% 5517
2017
Q3
$267K Buy
+22,500
New +$334K ﹤0.01% 4735

Other funds holding MDXG

Citigroup's MDXG Position: Q1 2026 in Review

Citigroup increased its MiMedx Group (MDXG) stake by 110% in Q1 2026, buying an estimated $72.6K and bringing the position to 27,545 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #4247.

Citigroup first reported a position in MDXG in Q3 2013 and has held it in 43 quarters since. The position peaked at $7.36M in Q2 2015. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Citigroup held 27,545 shares of MiMedx Group worth $109K as of Q1 2026.
  • Citigroup bought 14,407 MiMedx Group shares in Q1 2026, an estimated $72.6K.
  • MiMedx Group made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4247 holding.
  • Citigroup first reported a position in MiMedx Group in Q3 2013 and has held it in 43 quarters since.
  • Citigroup's MiMedx Group position peaked at $7.36M in Q2 2015.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.